Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Receivables: 2013-2025

Historic Receivables for Innoviva (INVA) over the last 3 years, with Sep 2025 value amounting to $93.5 million.

  • Innoviva's Receivables rose 2.70% to $93.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $346.1 million, marking a year-over-year increase of 0.28%. This contributed to the annual value of $86.4 million for FY2024, which is 2.72% up from last year.
  • Latest data reveals that Innoviva reported Receivables of $93.5 million as of Q3 2025, which was up 5.96% from $88.3 million recorded in Q2 2025.
  • In the past 5 years, Innoviva's Receivables registered a high of $94.0 million during Q2 2024, and its lowest value of $64.1 million during Q4 2022.
  • In the last 3 years, Innoviva's Receivables had a median value of $84.1 million in 2023 and averaged $83.3 million.
  • As far as peak fluctuations go, Innoviva's Receivables decreased by 6.33% in 2023, and later soared by 34.37% in 2024.
  • Over the past 4 years, Innoviva's Receivables (Quarterly) stood at $64.1 million in 2022, then skyrocketed by 31.22% to $84.1 million in 2023, then climbed by 2.72% to $86.4 million in 2024, then rose by 2.70% to $93.5 million in 2025.
  • Its Receivables stands at $93.5 million for Q3 2025, versus $88.3 million for Q2 2025 and $77.9 million for Q1 2025.